Leigh MacConell

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Richard M. Bergenstal, Carol Wysham, Leigh MacConell et al. · The Lancet · 2010 · 605 citations

Medicine, Pharmacology, Pharmacotherapy +15

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

Peter C. Gray, Amy L. Blount, Leigh MacConell et al. · Nature · 2000 · 588 citations

Life Sciences, Biochemistry, Molecular Biology +7

Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes

Dennis Kim, Leigh MacConell, Dongliang Zhuang et al. · Diabetes Care · 2007 · 446 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17